DEA Archived Press Releases

Press Releases before January 20, 2025
1183 Results - Showing 471 to 480
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...
PRESS RELEASE

Alameda resident sentenced for selling prescription drugs without a license and related charges

SAN FRANCISCO – Kenzo Mateo Tokuda was sentenced to 69 months in prison for possessing with intent to distribute alprazolam (commonly known as “Xanax”) and carrying a firearm during and in relation to a drug trafficking crime, announced United States Attorney Alex G. Tse and Drug Enforcement Administration Special Agent...
PRESS RELEASE

Mexican national residing in Modesto is sentenced to 17.5 years in prison for methamphetamine trafficking

SACRAMENTO, Calif. — Feliciano Ochoa Reyes, 34, of Mexico and Modesto was sentenced today by U.S. District Judge Garland E. Burrell, Jr. to 17-and-a-half years in prison for conspiring to distribute methamphetamine, U.S. Attorney McGregor W. Scott and U.S. Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced. According...
PRESS RELEASE

Two Afghan heroin traffickers sentenced in Manhattan federal court for conspiring to import heroin into the United States

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...
PRESS RELEASE

Former medical doctor sentenced to over three years prison for unlawfully prescribing oxycodone

SAN FRANCISCO – United States Attorney Alex G. Tse and U.S. Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced that Christopher Owens was sentenced to 41 months in prison for unlawfully prescribing oxycodone hydrochloride without a medical purpose. Owens pleaded guilty on March 20, 2018. According to his...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

Justice Department announces release of new fentanyl safety video for first responders

WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...
PRESS RELEASE

Methamphetamine conversion lab operator sentenced to more than 11 years

SACRAMENTO, Calif. — Jesus Bernal Urena, 52, of Mexico, was sentenced by U.S. District Judge Kimberly J. Mueller to 11 years and eight months in prison for a conspiracy to distribute methamphetamine, U.S. Attorney McGregor W. Scott and Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced. According to...
PRESS RELEASE

Two Chinese nationals charged with operating global opioid and drug manufacturing conspiracy resulting in deaths

WASHINGTON - While in Cleveland, Ohio, Attorney General Jeff Sessions today announced the unsealing of a 43-count indictment in federal court in Cleveland, which charges two Chinese citizens with operating a conspiracy that manufactured and shipped deadly fentanyl analogues and 250 other drugs to at least 25 countries and 37...
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...